Drug intelligence / Profile preview

NE gB2 + gD2

Development stage
Preclinical
Lead developer
BlueWillow Biologics
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intranasal
01

Overview

NE gB2 + gD2 is an investigational intranasal subunit vaccine for herpes simplex virus type 2 (HSV-2) that combines recombinant HSV-2 surface glycoproteins gD2 and gB2 formulated in a nanoemulsion adjuvant (NE01) to enhance mucosal and systemic immunity.[3] In preclinical guinea pig models of genital herpes, intranasal administration of the bivalent NE01-gD2/gB2 vaccine induced higher neutralizing antibody titers than a monovalent gD2 nanoemulsion vaccine, significantly reduced acute and recurrent genital disease, decreased viral shedding, and largely prevented dorsal root ganglion infection, supporting its potential for both prophylactic and therapeutic use against genital HSV-2 infection.[3]

Other names
NE01-gD2/gB2NE gD2 + gB2intranasal NE01-gD2/gB2 HSV-2 vaccine

Beyond the preview

Go deeper on NE gB2 + gD2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NE gB2 + gD2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call